Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Systemic β-Adrenergic Receptor Activation Augments the ex vivo Expansion and Anti-Tumor Activity of Vγ9Vδ2 T-Cells

Frontiers in Immunology(2020)10.3389/fimmu.2019.03082Source: DataRank Database

Systemic β-Adrenergic Receptor Activation Augments the ex vivo Expansion and Anti-Tumor Activity of Vγ9Vδ2 T-Cells is a research paper published in Frontiers in Immunology (2020). On theSindex it has a DataRank of 0. It has been cited 47 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access47 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)OA: goldTopics (52)IDs (PubMed, PMC)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Austin B. Bigley ORCID,Nadia H. Agha ORCID,Charles R. Pedlar ORCID,Daniel P. O’Connor ORCID,Richard A. Bond ORCID

Live enrichment

PubMed:32038628 PMC:PMC6993603

National Aeronautics and Space Administration

Grant: NNX12AB48G

National Aeronautics and Space Administration

Grant: NNX16AB29G

National Aeronautics and Space Administration

Grant: NNX16AG02G

National Institutes of Health

Grant: CA197527-01A1

NCI NIH HHS

Grant: R21 CA197527

National Institutes of Health

Grant: 1R21CA197527-01A1

CMV infection and NK-cell therapy for multiple myeloma

goldLicense: cc-by

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2019.03082/pdf

publisherhttps://www.frontiersin.org/article/10.3389/fimmu.2019.03082/full

repositoryhttp://hdl.handle.net/10150/638062

repositoryhttps://doaj.org/article/f17dc4ca5b40422c9322f680279a2730

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/6993603

Fields of Study

0301 basic medicine03 medical and health sciences0303 health sciences

MeSH Terms

T-LymphocytesCell LineHumansNeoplasmsBisoprololNadololReceptors, AdrenergicReceptors, Antigen, T-Cell, gamma-deltaAdrenergic beta-AgonistsAdrenergic beta-AntagonistsImmunotherapy, AdoptiveExerciseHematopoietic Stem Cell TransplantationTransplantation, HomologousLymphocyte ActivationCell ProliferationCytotoxicity, ImmunologicGraft vs Tumor EffectAdultFemaleMaleYoung Adult

Keywords

ExerciseBeta-blockersExercise ImmunologyAdoptive Transfer ImmunotherapyGamma-delta T-cellsAdultCytotoxicity, ImmunologicMaleT-LymphocytesImmunologyAdrenergic beta-AntagonistsLymphocyte ActivationImmunotherapy, AdoptiveCell LineNeoplasmsBisoprololHumansCell ProliferationGraft vs Tumor EffectHematopoietic Stem Cell TransplantationReceptors, Antigen, T-Cell, gamma-deltaRC581-607Adrenergic beta-AgonistsReceptors, AdrenergicNadololFemaleImmunologic diseases. Allergy

Sustainable Development Goals

SDG 3: 3. Good health

Systemic β-Adrenergic Receptor Activation Augments the ex vivo Expansion and Anti-Tumor Activity of Vγ9Vδ2 T-Cells

FAIR Checklist

Authors (9)

Funding (6 grants)

Open Access

Topics

Annotations (Europe PMC)